Consulting
Topics to explore
MFN and Nordic pharma
How MFN (Most Favoured Nation) is impacting commercial strategy for pharmaceutical companies in the Nordics, and what your teams need to consider.
Understand what's changing with MFN
Services
Topics to explore
Understand your patient
Gain clear insights into your patient care with our two top data solutions: Patient Impact Planner and Indication Insights.
Read more
Cases
Examples of our work
Browse the articles in this section to see examples of our work for other pharmaceutical companies.

If you’re interested in a specific service area, use the links on the right to navigate our portfolio.
Show me the cases
Topics to explore
Medice’s ADHD app launch: a digital health success story
Learn how Medice launched a commercially successful digital health app for ADHD families in Scandinavia.
Read the case
Insights
Forward Thinkers Review 2.0
Want to know what it takes to grow in the Nordic pharma industry over the next 3-5 years?
Download the report
Pharma Insights
We provide you with solid insight on which to base your strategy and tactical decisions. Some in a written format, others in the form of webinars.

Discover your options to the right - and let us know if you need anything else.
Sign up for our newsletter
Topics to explore
About
Your Nordic Partner
Signum supports your commercial growth across the four Nordic markets, with local teams in Denmark, Sweden, and Norway, as well as partnerships in Finland.
Learn about our Nordic services
Who are we
Decades of experience, in-depth knowledge of the Nordic markets and innovative data science make it possible for us to cut through the complexity to find the solutions you need for sound decision making.
Learn more
Topics to explore
Get in touch

About
>
Our team
>
Thomas Asmussen

Thomas Asmussen

Senior Consultant

Thomas brings deep expertise in market access strategy, stakeholder engagement, and the Nordic HTA landscape. With a strong commercial and consulting background, he drives strategic initiatives and business growth across the Nordic markets by turning complex access pathways into clear, relationship-driven strategies for global pharma clients.